Advanced supply contract for pandemic flu vaccine awarded to GSK and Baxter Healthcare

By Ewan Grist


On 16 August 2007, the Department of Health announced that it had awarded advanced supply contracts for a pandemic flu vaccine to both Baxter Healthcare and GSK. Under these contracts, upon identification of a pandemic influenza strain by the World Health Organisation, GSK and Baxter will manufacture and supply a tailor-made pandemic influenza vaccine to the NHS. The contracts are reported to be worth £155.4m over four years.